Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (SYRS)

Q4 2024 13F Holders as of 12/31/2024

Type / Class
Equity / Common Stock, $0.001 par value per share
Number of holders
44
Total Shares
5.22M
Shares change
-13.7M
Total reported value, excl. options
$1.2M
Value change
-$30M
Put/Call ratio
6.91
Number of buys
16
Number of sells
-36
Price
$0.23
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.